Physician
Morice, Natchez
Morice, Natchez was paid $4.63M by Medicaid between Jan 2018 and Dec 2024, across 87 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 13% of everything it billed.
33Billing provider infoMORICE, NATCHEZ
MORGAN CITY, LA 70380
MORGAN CITY, LA 70380
33aNPI1326022252assigned 12/05/2005
33bProvider typeObstetrics & Gynecology Physician
28Total paid$4.63M
24GClaims177,218
24DCodes billed87
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in Louisiana
Rank by total paid#2 of 126
Median peer was paid$155K
This provider vs. median30×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,477 | $1.27M | |
| 2019 | 35,449 | $1.02M | |
| 2020 | 33,274 | $977K | |
| 2021 | 2,244 | $21K | |
| 2022 | 13,026 | $235K | |
| 2023 | 41,873 | $831K | |
| 2024incomplete | 10,875 | $287K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 11,043 | 8,054 | $600K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.3% | 12,343 | 10,303 | $433K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7.6% | 11,101 | 9,889 | $352K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7.6% | 11,078 | 9,872 | $352K |
| 76830 | Ultrasound, transvaginal | 6.6% | 4,827 | 4,405 | $304K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 5.9% | 3,738 | 3,240 | $275K |
| 76819 | Fetal biophysical profile; without non-stress testing | 5.5% | 4,328 | 1,959 | $255K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.5% | 4,494 | 3,120 | $206K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 4.3% | 6,725 | 5,995 | $199K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 3.5% | 3,259 | 2,399 | $165K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.8% | 2,482 | 2,183 | $130K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.3% | 3,450 | 3,208 | $105K |
75 more codes
| 81025 | 2.1% | 19,121 | $95K | |
| 80050 | General health panel | 1.9% | 2,959 | $88K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.8% | 1,530 | $85K |
| 81513 | 1.4% | 1,032 | $65K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.3% | 760 | $59K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 2,644 | $59K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.1% | 873 | $51K |
| 82670 | <1% | 1,854 | $43K | |
| 84481 | <1% | 4,878 | $41K | |
| 84144 | <1% | 2,310 | $39K | |
| 84403 | <1% | 1,847 | $37K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,951 | $37K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 536 | $35K |
| 83001 | <1% | 1,959 | $29K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 600 | $29K |
| 83002 | <1% | 1,926 | $29K | |
| 87905 | <1% | 2,822 | $28K | |
| 83525 | <1% | 2,681 | $26K | |
| 84702 | <1% | 2,203 | $25K | |
| 82627 | <1% | 1,343 | $25K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,908 | $25K |
| 80053 | Comprehensive metabolic panel | <1% | 2,903 | $23K |
| 84439 | <1% | 3,568 | $23K | |
| 84270 | <1% | 1,271 | $22K | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 36 | $21K |
| 83735 | <1% | 3,512 | $20K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 712 | $19K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 375 | $19K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,523 | $19K |
| 87808 | <1% | 2,096 | $17K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 238 | $15K |
| 80061 | Lipid panel | <1% | 1,482 | $14K |
| 87625 | <1% | 331 | $11K | |
| 76641 | <1% | 108 | $9K | |
| H0049 | Alcohol and/or drug screening | <1% | 672 | $8K |
| 80305 | <1% | 886 | $8K | |
| 82120 | <1% | 2,423 | $7K | |
| 59430 | <1% | 63 | $6K | |
| 87210 | <1% | 2,207 | $4K | |
| 76536 | <1% | 71 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 61 | $4K |
| 81002 | <1% | 2,946 | $4K | |
| 99385 | <1% | 52 | $4K | |
| 83986 | <1% | 1,245 | $3K | |
| 76801 | <1% | 42 | $3K | |
| 90686 | <1% | 137 | $2K | |
| 84146 | <1% | 216 | $2K | |
| 82962 | <1% | 823 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 72 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 140 | $2K |
| 80074 | <1% | 237 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 323 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 41 | $2K |
| 82533 | <1% | 87 | $1K | |
| 83021 | <1% | 67 | $686.27 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 85 | $440.94 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 150 | $393.07 |
| 86850 | <1% | 210 | $355.86 | |
| 87340 | <1% | 100 | $316.11 | |
| 86762 | <1% | 85 | $299.46 | |
| 86803 | <1% | 92 | $265.41 | |
| 99441 | <1% | 26 | $249.69 | |
| 86787 | <1% | 86 | $214.14 | |
| 86592 | <1% | 125 | $214.08 | |
| 86709 | <1% | 74 | $189.16 | |
| 82105 | <1% | 28 | $133.60 | |
| 81003 | <1% | 100 | $98.82 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,222 | $94.60 |
| 84480 | <1% | 262 | $93.78 | |
| 81001 | <1% | 74 | $69.52 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 416 | $39.17 |
| 87081 | <1% | 46 | $25.70 | |
| 84436 | <1% | 124 | $4.33 | |
| 99000 | 0% | 479 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 863 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.